In preclinical mouse models of AD, microglial replacement is achieved by conditioning the brain through CSF1R inhibition and/or irradiation, followed by transplantation of hematopoietic or CDMCs, which can engraft and occupy the vacated niche (Fig. 2B). This evidence concerns the gene CSF1R and Alzheimer disease.